Chronic hepatitis B (CHB) infection affects 254 million people worldwide and led to 1.32 million deaths from cirrhosis and hepatocellular carcinoma (HCC) in 2024. Antiviral therapy can reduce the risk of complications, but viral biomarkers are ....
Globally, approximately 15–30% of HIV-infected individuals exhibit serological characteristics of anti-HBc (antibody to HBV core protein) positivity and HBsAg (HBV surface antigen) negativity, which may reflect the presence of occult HBV infection...
A study by the University of Southern California, published in The Journal of Infectious Diseases, explores the potential of the novel marker HBV RNA in assessing the likelihood of sustained partial cure in patients who discontinue therapy.
In November 2024, the American Association for the Study of Liver Diseases (AASLD) successfully held its conference in Washington, D.C., USA.
Phone · +86 021-50720200 Address · Building 15B, No. 528 Ruiqing Road, East District, Zhangjiang High tech Park, Shanghai Email · hr@rdbio.com（Domestic Affairs） sales@rdbio.com（International Trade）
